Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.

Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG

Open source

DOI
10.1002/pul2.12317
Published
2023 Oct
Container
Pulmonary circulation
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pul2.12317,
  title = {Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.},
  author = {Morland K and Gerges C and Elwing J and Visovatti SH and Weatherald J and Gillmeyer KR and Sahay S and Mathai SC and Boucly A and Williams PG and Harikrishnan S and Minty EP and Hobohm L and Jose A and Badagliacca R and Lau EMT and Jing ZC and Vanderpool RR and Fauvel C and Leonidas Alves J Jr and Strange G and Pulido T and Qian J and Li M and Mercurio V and Zelt JGE and Moles VM and Cirulis MM and Nikkho SM and Benza RL and Elliott CG},
  year = {2023},
  journal = {Pulmonary circulation},
  doi = {10.1002/pul2.12317},
  url = {https://doi.org/10.1002/pul2.12317}
}

RIS

TY  - JOUR
TI  - Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.
AU  - Morland K
AU  - Gerges C
AU  - Elwing J
AU  - Visovatti SH
AU  - Weatherald J
AU  - Gillmeyer KR
AU  - Sahay S
AU  - Mathai SC
AU  - Boucly A
AU  - Williams PG
AU  - Harikrishnan S
AU  - Minty EP
AU  - Hobohm L
AU  - Jose A
AU  - Badagliacca R
AU  - Lau EMT
AU  - Jing ZC
AU  - Vanderpool RR
AU  - Fauvel C
AU  - Leonidas Alves J Jr
AU  - Strange G
AU  - Pulido T
AU  - Qian J
AU  - Li M
AU  - Mercurio V
AU  - Zelt JGE
AU  - Moles VM
AU  - Cirulis MM
AU  - Nikkho SM
AU  - Benza RL
AU  - Elliott CG
PY  - 2023
JO  - Pulmonary circulation
DO  - 10.1002/pul2.12317
UR  - https://doi.org/10.1002/pul2.12317
ER  - 

APA

K, M., C, G., J, E., SH, V., J, W., KR, G., S, S., SC, M., A, B., PG, W., S, H., EP, M., L, H., A, J., R, B., EMT, L., ZC, J., RR, V., C, F., Jr, L. A. J., G, S., T, P., J, Q., M, L., V, M., JGE, Z., VM, M., MM, C., SM, N., RL, B., & CG, E. (2023). Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.. Pulmonary circulation. https://doi.org/10.1002/pul2.12317

Source records